LA MIRADA, CA, Oct 01, 2012 (MARKETWIRE via COMTEX) — BioLargo, Inc. BLGO +12.00% announced today that it had retained Bulldog Marketing & Sales, Inc., out of New York and Bulldog’s strategic Public Relations partner, K. Sutherland PR, of Irvine, CA to act as “senior strategists” as it prepares to launch a national marketing and public relations campaign to support its Odor-No-More(R) branded Cat Litter Additive and Central Garden & Pet’s national distribution channel.
Led by John Cullen, named in the Pet Industry’s Top 25 to Watch for 2011 by Pet Product News, Bulldog specializes in the marketing and sales of pet products. With over 15 years in the business, Cullen has led successful campaigns for both large and small companies. “After seeing Odor-No-More’s product demo at SuperZoo 2012, I knew I had to get involved,” stated Cullen. “With its instant odor removal and rapid liquid absorption, all packed into its small lightweight shaker bottle packaging, Odor-No-More is a game changer in the litter category.”
“We are excited to add these key team members who have proven marketing expertise,” stated BioLargo’s president, Dennis Calvert. “We are leveraging the excitement generated at SuperZoo with a marketing campaign that will utilize a multi-media, multi-channel strategy to drive customer awareness.”
The top two pain-points and consumer complaints about cat ownership is litter box urine smell and heavy litter bags. Odor-No-More solves both of these issues with one, simple to use product. In addition, early test market results show that once consumers try Odor-No-More they come back to purchase again and again — making a product trial the central focus of BioLargo’s marketing campaign.
About Bulldog Marketing & Sales, Inc.
Bulldog Marketing & Sales, Inc. is a full service agency formed in 2009 by pet industry veteran John Cullen. It has over 15 years of marketing and sales experience ranging from marketing strategy to new product development and retail sell-in. It has increased sales and developed new products for the Fortune 500 as well as for start-ups. Marketing & sales expertise includes: Pet Products, Consumer Packaged Goods and Consumer Electronics.
Bulldog is headquartered in the New York City. For more information, visit www.bulldogms.com .
About BioLargo, Inc.
BioLargo’s business strategy is to harness and deliver Nature’s Best Solution(R) — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. Its proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. The technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company’s goal is to improve the quality of life for people worldwide, while it protects the environment, and produces positive economic results for our customers, partners, and shareholders. Its website is www.BioLargo.com . The company’s Odor-No-More(R) product was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry publication, as well as a Best New Product SuperZoo Award, and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. ( www.OdorNoMore.com ). In early 2011, the company signed an exclusive license agreement for the use of its technology in pet products with industry leader Central Garden & Pet. BioLargo also owns a 50% interest in the Isan System, already commercialized in Australia, which was honored with a “Top 50 Water Company for the 21st Century” award by the Artemis Project.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2011.